1. Home
  2. FXNC vs ADAG Comparison

FXNC vs ADAG Comparison

Compare FXNC & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First National Corporation

FXNC

First National Corporation

HOLD

Current Price

$29.84

Market Cap

266.8M

Sector

Finance

ML Signal

HOLD

Logo Adagene Inc.

ADAG

Adagene Inc.

HOLD

Current Price

$3.30

Market Cap

260.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FXNC
ADAG
Founded
1907
2011
Country
United States
China
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
266.8M
260.3M
IPO Year
2012
2020

Fundamental Metrics

Financial Performance
Metric
FXNC
ADAG
Price
$29.84
$3.30
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.25
AVG Volume (30 Days)
58.8K
310.1K
Earning Date
05-12-2026
04-01-2026
Dividend Yield
2.43%
N/A
EPS Growth
96.00
N/A
EPS
0.54
N/A
Revenue
$7,717,000.00
N/A
Revenue This Year
$12.21
N/A
Revenue Next Year
$2.93
N/A
P/E Ratio
$53.54
N/A
Revenue Growth
7.40
N/A
52 Week Low
$20.81
$1.44
52 Week High
$31.21
$4.85

Technical Indicators

Market Signals
Indicator
FXNC
ADAG
Relative Strength Index (RSI) 52.57 36.27
Support Level $28.72 $2.78
Resistance Level $30.90 $3.53
Average True Range (ATR) 1.25 0.33
MACD -0.08 -0.07
Stochastic Oscillator 76.73 7.07

Price Performance

Historical Comparison
FXNC
ADAG

About FXNC First National Corporation

First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. The Company operates through two reportable operating segments: Community Banking and wealth management. The Community Banking segment involves making loans and generating deposits from individuals, businesses, and charitable organizations. Wealth Management Services offers corporate trustee services, trust and estate administration, IRA administration and custody services. The company has revenue from Community Banking segment.

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.

Share on Social Networks: